Fig. 5From: Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapyTransfusion independence and exposure-adjusted transfusion rates. a Patients who achieved CR. b Patients who did not achieve CR. Transfusion-independent patients are defined as those who have ≥ 8 weeks (56 days) without any type of transfusion at any point of the study. All other patients are considered transfusion-dependent. Analysis set, N = number of patients with platelet results in the cycle; patients, n = number of patients meeting recovery criteria in the cycle. Abbreviations: CR, complete remission; PRBC, packed red blood cellsBack to article page